Cardiology
Study: Heart-attack risk tools fail to flag nearly half of future patients
Ti AI ṣe iroyin Àwòrán tí AI ṣe Ti ṣayẹwo fun ododo
A Mount Sinai–led study finds that commonly used heart-attack risk calculators and symptom-based screening fail to identify nearly half of people who will soon experience a first heart attack. The brief report, published November 21 in JACC: Advances, underscores limitations in current prevention strategies and argues for earlier imaging to detect silent plaque.
New research from the Amsterdam University Medical Center and St. Bartholomew's Hospital indicates that the Apple Watch can detect atrial fibrillation four times more frequently than standard care, potentially reducing stroke risk. The studies involved patients wearing the device to monitor heart rhythms over several months. This technology uses sensors to identify irregular heartbeats that could lead to blood clots.
Ti AI ṣe iroyin
CNET has updated its recommendations for reliable at-home blood pressure monitors, all FDA-approved and endorsed by cardiologists. The list emphasizes accuracy, user-friendliness, and features like EKG integration for those tracking heart health. Monitoring is advised for everyone to establish baselines, especially for high-risk groups.
A new study revealed that Baxdrostat significantly reduces blood pressure in patients with resistant hypertension. The findings challenge existing treatments and suggest a new option for managing this condition. Results were highlighted as part of recent medical advancements.